Outcome switching

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 15:37, May 13, 2017 by Kmdenmark (talk | contribs) (added cat)

Outcome switching is when authors of a clinical trial "move the goal posts" during a trial to achieve the desired results.

The PACE trial authors, in a clinical trial of ME/CFS patients undergoing GET/CBT, employed this tactic.

Articles on Outcome switching in clinical trials[edit | edit source]

Tracking outcome switching

PACE trial[edit | edit source]

  • David Tuller spoke about and answered questions on the PACE trial and its flaws.
Feb 28, 2016, David Tuller gave a speech with Q&As. That speech can be viewed here.[2]
Feb 27, 2016, While in Amsterdam at The Forgotten Plague Conference, David Tuller gave an interview with Frank Twisk discussing the flaws of the Pace trial. That interview can be viewed here.[3]

Learn more[edit | edit source]

See also[edit | edit source]

  • Alem Matthees won the Freedom of Information Act request for PACE trial data.

References[edit | edit source]